Closure Devices Used in PFO Treatment More Beneficial Than Medication Alone
from Cardiovascular Business
A new trial suggested patients exhibiting patent foramen ovale (PFO), who received a medical device to close the opening in the heart after a stroke, had better outcomes compared to patients who received only stroke-preventing medications. Results of the trial were presented at the American College of Cardiology's 67th Annual Scientific Session in Orlando on March 12.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063